Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Frank B CortazarZoe A KibbelaarIlya G GlezermanAla AbudayyehOmar MamloukShveta S MotwaniNaoka MurakamiSandra M HerrmannSandhya ManoharAnushree C ShiraliAbhijat KitchluShayan ShirazianAmer AssalAnitha VijayanAmanda DeMauro RenaghanDavid I Ortiz-MeloSunil RangarajanA Bilal MalikJonathan J HoganAlex R DinhDaniel Sanghoon ShinKristen A MarroneZain MithaniDouglas B JohnsonAfrooz HosseiniDeekchha UpretyShreyak SharmaShruti GuptaKerry L ReynoldsMeghan E SiseDavid E LeafPublished in: Journal of the American Society of Nephrology : JASN (2020)
This multicenter study identifies insights into the risk factors, clinical features, histopathologic findings, and renal and overall outcomes in patients with immune checkpoint inhibitor-associated AKI.